Drug
foscarbidopa/foslevodopa
Marketed as VYALEV.
Generic name
foscarbidopa/foslevodopa
Brand names
VYALEV
First FDA approval
2024-10-16
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA216962 | VYALEV | 2024-10-16 | ABBVIE |
Manufacturers
ABBVIE
Frequently asked questions
When was foscarbidopa/foslevodopa FDA approved?
Earliest FDA approval on record: 2024-10-16.
What brand names are sold as foscarbidopa/foslevodopa?
VYALEV.
Sources
Appeal a foscarbidopa/foslevodopa denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com